Novartis AG (SWX:NOVN)

Market Cap	197.41B
Revenue (ttm)	44.95B
Net Income (ttm)	11.48B
Shares Out	1.92B
EPS (ttm)	5.82
PE Ratio	17.68
Forward PE	14.40
Dividend	3.50 (3.49%)
Ex-Dividend Date	Mar 11, 2025

Volume	3,543,420
Average Volume	2,835,194
Open	99.45
Previous Close	100.42
Day's Range	99.45 - 102.98
52-Week Range	81.10 - 106.88
Beta	0.44
RSI	50.95
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVN

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD